Cargando…
The unfolded protein response in amyotrophic later sclerosis: results of a phase 2 trial
Strong evidence suggests that endoplasmic reticulum stress plays a critical role in the pathogenesis of amyotrophic lateral sclerosis (ALS) through altered regulation of proteostasis. Robust preclinical findings demonstrated that guanabenz selectively inhibits endoplasmic reticulum stress-induced eI...
Autores principales: | Dalla Bella, Eleonora, Bersano, Enrica, Antonini, Giovanni, Borghero, Giuseppe, Capasso, Margherita, Caponnetto, Claudia, Chiò, Adriano, Corbo, Massimo, Filosto, Massimiliano, Giannini, Fabio, Spataro, Rossella, Lunetta, Christian, Mandrioli, Jessica, Messina, Sonia, Monsurrò, Maria Rosaria, Mora, Gabriele, Riva, Nilo, Rizzi, Romana, Siciliano, Gabriele, Silani, Vincenzo, Simone, Isabella, Sorarù, Gianni, Tugnoli, Valeria, Verriello, Lorenzo, Volanti, Paolo, Furlan, Roberto, Nolan, John M, Abgueguen, Emmanuelle, Tramacere, Irene, Lauria, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8557337/ https://www.ncbi.nlm.nih.gov/pubmed/33905493 http://dx.doi.org/10.1093/brain/awab167 |
Ejemplares similares
-
Protein misfolding, amyotrophic lateral sclerosis and guanabenz: protocol for a phase II RCT with futility design (ProMISe trial)
por: Bella, Eleonora Dalla, et al.
Publicado: (2017) -
Erythropoietin in amyotrophic lateral sclerosis: a multicentre, randomised, double blind, placebo controlled, phase III study
por: Lauria, Giuseppe, et al.
Publicado: (2015) -
Comparative Analysis of C9orf72 and Sporadic Disease in a Large Multicenter ALS Population: The Effect of Male Sex on Survival of C9orf72 Positive Patients
por: Trojsi, Francesca, et al.
Publicado: (2019) -
The HFE p.H63D (p.His63Asp) Polymorphism Is a Modifier of ALS Outcome in Italian and French Patients with SOD1 Mutations
por: Canosa, Antonio, et al.
Publicado: (2023) -
Proteostasis and ALS: protocol for a phase II, randomised, double-blind, placebo-controlled, multicentre clinical trial for colchicine in ALS (Co-ALS)
por: Mandrioli, Jessica, et al.
Publicado: (2019)